Wird geladen...
Voxelotor: A Ray of Hope for Sickle Disease
Sickle cell disease is one challenging blood disorder, affecting around 100,000 people in the United States alone. None of the currently approved drugs can modify the underlying pathology of the disease. Voxelotor, first of its kind, is an orally administered drug that can alter the underlying disea...
Gespeichert in:
| Veröffentlicht in: | Cureus |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cureus
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7100618/ https://ncbi.nlm.nih.gov/pubmed/32257653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.7105 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|